Eponox
Retirée du marché américain le 28 September 2023 (selon le DSLD)
XL Xero Limits, food supplement from the US market
Label withdrawn from the US market. Eponox (XL Xero Limits), a food supplement au code-barres 891597002313, is described by its US market label. The French and European rules we can apply to this label flag no particular point. Doses of folates, niacine are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- XL Xero Limits
- Barcode
- 891597002313
- Form
- Tablet
- One serving
- 3 tablets
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Microcrystalline Cellulose, Calcium Carbonate, Stearic Acid, Magnesium Stearate, Silica, Hydroxypropyl Methylcellulose, Titanium Dioxide, Triacetin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Niacin | Vitamin | 75 mg |
| Vitamin B-6 | Vitamin | 25 mg |
| Folate | Vitamin | 800 µg |
| Vitamin B12 | Vitamin | 100 µg |
| Iron | Mineral | 3 mg |
| Eponox | Blend | 3.466 Gram(s) |
| Nitric Oxide Co-Factors | Blend | not stated |
| Arginine AKG | Other substance | not stated |
| Arginine Ethyl Ester | Other substance | not stated |
| L-Arginine Hydrochloride | Amino acid | not stated |
| Gynostemma pentaphyllum extract (Gynostemma pentaphyllum) | Plant | not stated |
| Cnidium monnieri powder (Cnidium monnieri) | Plant | not stated |
| Norvaline | Amino acid | not stated |
| Citrulline | Amino acid | not stated |
| EPO Blood Building Technology | Blend | not stated |
| Arachidonic Acid | Fatty acid | not stated |
| Echinacea pupurea extract (Echinacea purpurea) | Plant | not stated |
| Portulaca oleracea extract (Portulaca oleracea) | Plant | not stated |
| Cobalt | Mineral | not stated |
| Pharmaceutical Meter Dose Controlled Delivery: | ||
| Hydrophilic Hypromellose Polymers | Other | not stated |
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Echinacea pupurea extract
Read the warning, when it applies and the studies cited
ECHINACEA - ECHINACEA PURPUREA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a progressive systemic disease such as tuberculosis, collagenosis, multiple sclerosis, or an immune system disorder (EMA 2015; Gardner and McGuffin 2013; Brinker 2010).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications to suppress the immune system (Brinker 2010; Mills and Bone 2005).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: Preparations containing herb top.
Stop use if hypersensitivity/allergy occurs (MHRA 2018; EMA 2015; Kligler 2003; WHO 1999).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : XL Xero Limits
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.